Versant Capital Management, Inc Alkermes Plc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 846 shares of ALKS stock, worth $27,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
846
Previous 716
18.16%
Holding current value
$27,934
Previous $20,000
35.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$961 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$611 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$405 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$291 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$250 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.42B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...